Retrospective analysis compared contrast-enhanced harmonic endoscopic ultrasound with CT and MRI, revealing superior diagnostic efficacy for periampullary masses.
Background: Periampullary masses encompass both benign and malignant lesions that are clinically challenging to differentiate. This study aimed to investigate the diagnostic value of contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) for periampullary masses and compare its performance with computed tomography (CT) and magnetic resonance imaging (MRI). Methods: We conducted a retrospective analysis of 54 patients with pathologically confirmed malignant periampullary masses or benign lesions validated by ≥1-year follow-up. Diagnostic efficacy of CH-EUS was evaluated against CT and MRI. Results: All malignant masses exhibited arterial-phase hypo-enhancement, while 78.94% of benign lesions showed iso-enhancement. Venous-phase hypo-enhancement was observed in 94.28% of malignancies and 57.89% of benign cases demonstrated iso-enhancement. CH-EUS demonstrated superior diagnostic accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) compared to CT (all p<0.05). Its accuracy and sensitivity also exceeded those of MRI (p<0.05). Conclusion: CH-EUS effectively differentiates benign and malignant periampullary masses, demonstrating high clinical utility.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: